Dr. Andrea Franson, MD

NPI: 1447544671
Total Payments
$9,908
2024 Payments
$8,650
Companies
6
Transactions
8

Payment Breakdown by Category

Consulting$9,367 (94.5%)
Research$415.44 (4.2%)
Food & Beverage$125.65 (1.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $9,367 4 94.5%
Unspecified $415.44 2 4.2%
Food and Beverage $125.65 2 1.3%

Payments by Type

General
$9,493
6 transactions
Research
$415.44
2 transactions

Top Paying Companies

Company Total Records Latest Year
SpringWorks Therapeutics, Inc. $3,600 1 $0 (2024)
Day One Biopharmaceuticals $3,075 1 $0 (2024)
Alexion Pharmaceuticals, Inc. $1,560 1 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $1,244 2 $0 (2023)
Regeneron Pharmaceuticals, Inc. $415.44 2 $0 (2024)
AbbVie, Inc. $13.71 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $8,650 5 SpringWorks Therapeutics, Inc. ($3,600)
2023 $1,244 2 Bayer Healthcare Pharmaceuticals Inc. ($1,244)
2018 $13.71 1 AbbVie, Inc. ($13.71)

All Payment Transactions

8 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/05/2024 Day One Biopharmaceuticals OJEMDA (Drug) Consulting Fee Cash or cash equivalent $3,075.00 General
Category: ONCOLOGY
10/24/2024 SpringWorks Therapeutics, Inc. Consulting Fee Cash or cash equivalent $3,600.00 General
06/30/2024 Regeneron Pharmaceuticals, Inc. LIBTAYO (Biological) In-kind items and services $259.37 Research
Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY
04/16/2024 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,560.00 General
03/08/2024 Regeneron Pharmaceuticals, Inc. LIBTAYO (Biological) In-kind items and services $156.07 Research
Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY
09/14/2023 Bayer Healthcare Pharmaceuticals Inc. Vitrakvi (Drug) Consulting Fee Cash or cash equivalent $1,132.25 General
Category: Oncology
06/04/2023 Bayer Healthcare Pharmaceuticals Inc. Vitrakvi (Drug) Food and Beverage In-kind items and services $111.94 General
Category: Oncology
01/16/2018 AbbVie, Inc. Food and Beverage In-kind items and services $13.71 General

Research Studies & Clinical Trials

Study Name Company Amount Records
LIBTAYO CLINICAL PUBLICATION PROGRAM Regeneron Pharmaceuticals, Inc. $415.44 2

About Dr. Andrea Franson, MD

Dr. Andrea Franson, MD is a Pediatrics healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1447544671.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrea Franson, MD has received a total of $9,908 in payments from pharmaceutical and medical device companies, with $8,650 received in 2024. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($9,367).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatrics, Pediatric Hematology-Oncology
  • Location Ann Arbor, MI
  • Active Since 06/06/2011
  • Last Updated 02/10/2020
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1447544671

Products in Payments

  • OJEMDA (Drug) $3,075
  • Vitrakvi (Drug) $1,244
  • LIBTAYO (Biological) $415.44

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Ann Arbor